Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Today in court
Two events today:

MMP HTC Appeal - Pre-Trial Oral Arguments (Washington DC)

TPL Bankruptcy: Debtor and the Committee shall file a revised Joint Disclosure Statement and Plan by December 15, 2014, with a redlined copy to be lodged with the Courtroom Deputy. The approval of the Joint Disclosure Statement is CONTINUED to December 19, 2014 at 10:00 a.m. Objections to the revised documents may be raised orally at the hearing.
Share
New Message
Please login to post a reply